20 years helping business leaders deliver alpha. View our success stories
20 years helping business leaders deliver alpha. View our success stories
By Humatica
As the fall-out from COVID-19 threatens to sink entire portfolios, PE sponsors and CEO’s need to walk a tightrope between preserving organisational capabilities in order to resume growth in case of a rebound in 2H 2020, while at the same time preparing to survive a protracted recession or even depression if things go wrong.
Our latest HumaticaCorner explores the options for portfolio managers and CEOs.
Measuring organizational performance is difficult, especially in a way that is both systematic and genuinely useful for decision-making. In a recent Alpha Talks conversation, Ueli…
Read more
Unpacking the root causes behind underperformance and how to resolve them It’s a familiar scene: Over dinner, a client lamenting inconsistent results across their portfolio…
Read more
Alpha Talks: Getting the operating model right as a complex carve-out CEO | Jon Newhard, Yunex Traffic CEO In this episode of Humatica Alpha Talks,…
Read more
Receive our news and valuable perspectives on organizational effectiveness each month.
